1887
Rapid communication Open Access
Like 0

Abstract

In the World Health Organization European Region, the 2018/19 influenza season started in week 49 2018, crossing 10% virus-positivity in sentinel surveillance specimens. At week 5 2019, activity remained elevated with positivity rates at 55%. Both A(H1N1)pdm09 and A(H3N2) viruses circulated widely and detection levels in primary care and hospital settings were similar to past seasons. Hospitalisation data may suggest an increased susceptibility to A(H1N1)pdm09 virus in older age groups.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2019.24.9.1900125
2019-02-28
2019-05-26
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2019.24.9.1900125
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/24/9/eurosurv-24-9-1.html?itemId=/content/10.2807/1560-7917.ES.2019.24.9.1900125&mimeType=html&fmt=ahah

References

  1. European Centre for Disease Prevention and Control (ECDC)-World Health Organization Regional Office for Europe (WHO/Europe). Flu News Europe, Joint ECDC-WHO weekly influenza update 2019. Stockholm/Geneva: ECDC-WHO/Europe; [Accessed February 11]. Available from: www.flunewseurope.org
  2. World Health Organization Regional Office for Europe/European Centre for Disease Prevention and Control (WHO/ECDC). Influenza Surveillance Country, Territory and Area Profiles 2017. Copenhagen/Stockholm: WHO/ECDC; 2017. Available from: http://www.euro.who.int/__data/assets/pdf_file/0007/356119/InfluenzaSurveillanceProfiles_2017_en.pdf
  3. European Centre for Disease Prevention and Control (ECDC). Annual Epidemiological Report 2016-Seasonal Influenza. Stockholm: ECDC; 2016. Available from: https://ecdc.europa.eu/en/publications-data/seasonal-influenza-annual-epidemiological-report-2016-17-season
  4. Adlhoch C, Snacken R, Melidou A, Ionescu S, Penttinen PThe European Influenza Surveillance Network. Dominant influenza A(H3N2) and B/Yamagata virus circulation in EU/EEA, 2016/17 and 2017/18 seasons, respectively. Euro Surveill. 2018;23(13):18-00146.  https://doi.org/10.2807/1560-7917.ES.2018.23.13.18-00146  PMID: 29616611 
  5. Public health Agency Sweden (PHAS). Influensarapport vecka 3 Sasongen 2018-2019. [Influenza report week 3 Season 2018-2019]. Stockholm: PHAS; 2019. Swedish. Available from: https://www.folkhalsomyndigheten.se/globalassets/statistik-uppfoljning/smittsamma-sjukdomar/veckorapporter-influensa/2018-2019/influensarapport-2019-03.pdf
  6. Dawood FS, Iuliano AD, Reed C, Meltzer MI, Shay DK, Cheng PY, et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis. 2012;12(9):687-95.  https://doi.org/10.1016/S1473-3099(12)70121-4  PMID: 22738893 
  7. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289(2):179-86.  https://doi.org/10.1001/jama.289.2.179  PMID: 12517228 
  8. Nielsen J, Vestergaard LS, Richter L, Schmid D, Bustos N, Asikainen T, et al. European all-cause excess and influenza-attributable mortality in the 2017/18 season: should the burden of influenza B be reconsidered? Clin Microbiol Infect. 2019;S1198-743X(19)30058-8. Forthcoming.
  9. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med. 2009;361(20):1945-52.  https://doi.org/10.1056/NEJMoa0906453  PMID: 19745214 
  10. Skowronski DM, Leir S, Sabaiduc S, Murti M, Dickinson JA, Olsha R, et al. Interim estimates of 2018/19 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, January 2019. Euro Surveill. 2019;24(4):1900055.  https://doi.org/10.2807/1560-7917.ES.2019.24.4.1900055  PMID: 30696523 
  11. Chiu SS, Kwan MY, Feng S, Chan EL, Chua H, Wong JS, et al. Early season estimate of influenza vaccination effectiveness against influenza hospitalisation in children, Hong Kong, winter influenza season 2018/19. Euro Surveill. 2019;24(5):1900056.  https://doi.org/10.2807/1560-7917.ES.2019.24.5.1900056  PMID: 30722814 
  12. Doyle JD, Chung JR, Kim SS, Gaglani M, Raiyani C, Zimmerman RK, et al. Interim Estimates of 2018-19 Seasonal Influenza Vaccine Effectiveness - United States, February 2019. MMWR Morb Mortal Wkly Rep. 2019;68(6):135-9.  https://doi.org/10.15585/mmwr.mm6806a2  PMID: 30763298 
  13. Belongia EA, Simpson MD, King JP, Sundaram ME, Kelley NS, Osterholm MT, et al. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. Lancet Infect Dis. 2016;16(8):942-51.  https://doi.org/10.1016/S1473-3099(16)00129-8  PMID: 27061888 
/content/10.2807/1560-7917.ES.2019.24.9.1900125
Loading

Data & Media loading...

Comment has been disabled for this content
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error